Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia

BACKGROUND: Fluoroquinolone antibiotics are frequently utilized in pediatric oncology patients as prophylaxis or step‐down therapy following broad spectrum beta‐lactam therapy for febrile neutropenia. Concerns regarding neurotoxicity limit the use of these agents. No studies have evaluated the assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Karol, Seth E., Sun, Yilun, Tang, Li, Pui, Ching‐Hon, Ferrolino, Jose, Allison, Kim J., Cross, Shane J., Evans, William E., Crews, Kristine R., Jeha, Sima, Wolf, Joshua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520302/
https://www.ncbi.nlm.nih.gov/pubmed/32710497
http://dx.doi.org/10.1002/cam4.3249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520302/
https://www.ncbi.nlm.nih.gov/pubmed/32710497
http://dx.doi.org/10.1002/cam4.3249

Ejemplares similares